Tag: FDA

Medtech veteran tipped to lead AI oversight at FDA

HHS is standing up two new FDA deputy commissioner posts, with a medtech veteran tipped to oversee AI.

By

FDA outlines three-stage path for digital measures in trials

FDA centers lay out a three-stage evidence path for wearable and sensor trial endpoints.

By

Study finds almost no FDA-cleared AI devices tested on outcomes

A PLOS Digital Health study finds only three of 1,357 FDA-cleared AI devices were ever tested on patient outcomes.

By

FDA gives first US clearance to Vitestro’s vein-finding blood draw robot

The FDA cleared Vitestro's Aletta as the first fully autonomous blood draw system in the US.

By

FDA maps a doctor-like testing path for generative AI devices

The FDA's new discussion paper proposes doctor-style competency testing for generative AI medical devices before they reach patients.

By

FDA roster of cleared AI medical devices passes 1,500

FDA marketing authorizations for AI-powered medical tools have passed 1,500, with oncology among the fastest-growing categories.

By

FDA and CMS court AI health startups in closed-door demo day

FDA and CMS hosted 10 AI health companies at a private demo day as they weigh clinical AI policy.

By

White House convenes clinical AI experts for standards sprint on evaluation

The White House, FDA, and ONC launch a month-long effort to create consensus principles for clinical AI benchmarking.

By